These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 34394187)
21. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation. Winner JG; Carhart JM; Altar CA; Goldfarb S; Allen JD; Lavezzari G; Parsons KK; Marshak AG; Garavaglia S; Dechairo BM Curr Med Res Opin; 2015; 31(9):1633-43. PubMed ID: 26086890 [TBL] [Abstract][Full Text] [Related]
22. Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System. Mroz P; Michel S; Allen JD; Meyer T; McGonagle EJ; Carpentier R; Vecchia A; Schlichte A; Bishop JR; Dunnenberger HM; Yohe S; Thyagarajan B; Jacobson PA; Johnson SG Front Genet; 2021; 12():712602. PubMed ID: 34745204 [TBL] [Abstract][Full Text] [Related]
23. Improving Pain Management with Pharmacogenomics: A General Introduction. Schuh MJ; Randles H; Crosby S J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):114-119. PubMed ID: 32186418 [TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomics: Prescribing Precisely. Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008 [TBL] [Abstract][Full Text] [Related]
25. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes. Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366 [TBL] [Abstract][Full Text] [Related]
26. Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available. Samwald M; Xu H; Blagec K; Empey PE; Malone DC; Ahmed SM; Ryan P; Hofer S; Boyce RD PLoS One; 2016; 11(10):e0164972. PubMed ID: 27764192 [TBL] [Abstract][Full Text] [Related]
27. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing. van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729 [TBL] [Abstract][Full Text] [Related]
28. Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians. Overby CL; Devine EB; Abernethy N; McCune JS; Tarczy-Hornoch P J Biomed Inform; 2015 Jun; 55():249-59. PubMed ID: 25957826 [TBL] [Abstract][Full Text] [Related]
29. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing? Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375 [TBL] [Abstract][Full Text] [Related]
30. Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior. Waldman L; Shuman C; Cohn I; Kaiser A; Chitayat D; Wasim S; Hazell A Pharmacogenomics; 2019 Apr; 20(5):319-329. PubMed ID: 30983503 [TBL] [Abstract][Full Text] [Related]
31. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Oscanoa TJ; Lizaraso F; Carvajal A Eur J Clin Pharmacol; 2017 Jun; 73(6):759-770. PubMed ID: 28251277 [TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetic testing in psychiatric inpatients with polypharmacy is associated with decreased medication side effects but not via medication changes. Collins AR; Kung S; Ho JT; Wright JA; Dammen KC; Johnson EK; Lapid MI; Leung JG J Psychiatr Res; 2020 Jul; 126():105-111. PubMed ID: 32442780 [TBL] [Abstract][Full Text] [Related]
33. Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting. Haga SB; Mills R; Moaddeb J; Liu Y; Voora D Pharmgenomics Pers Med; 2021; 14():785-796. PubMed ID: 34276225 [TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics for Primary Care: An Overview. Rollinson V; Turner R; Pirmohamed M Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198260 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders. Hess GP; Fonseca E; Scott R; Fagerness J Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725 [TBL] [Abstract][Full Text] [Related]
37. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade. Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514 [TBL] [Abstract][Full Text] [Related]